| Title | Date | PubMed ID |
|---|
| Influence of proton pump inhibitors and VKORC1 mutations on CYP2C9-mediated dose requirements of vitamin K antagonist therapy: a pilot study. | 2014 Nov | 25142093 |
| Brønsted analysis reveals Lys218 as the carboxylase active site base that deprotonates vitamin K hydroquinone to initiate vitamin K-dependent protein carboxylation. | 2006 Nov 7 | 17073445 |
| The vitamin K-dependent carboxylase has been acquired by Leptospira pathogens and shows altered activity that suggests a role other than protein carboxylation. | 2005 Oct 14 | 16061481 |
| Developmental changes of vitamin K epoxidase and reductase activities involved in the vitamin K cycle in human liver. | 2000 Jan | 10690708 |
| Propeptide and glutamate-containing substrates bound to the vitamin K-dependent carboxylase convert its vitamin K epoxidase function from an inactive to an active state. | 1997 Aug 19 | 9256436 |
| Profactor IX propeptide and glutamate substrate binding sites on the vitamin K-dependent carboxylase identified by site-directed mutagenesis. | 1996 Jul 26 | 8663364 |
| Mutagenesis of vitamin K-dependent carboxylase demonstrates a carboxyl terminus-mediated interaction with vitamin K hydroquinone. | 1995 Mar 10 | 7890642 |
| Vitamin K-dependent carboxylase: affinity purification from bovine liver by using a synthetic propeptide containing the gamma-carboxylation recognition site. | 1989 Sep | 2780546 |
| Oxygen dependence of vitamin K-dependent carboxylase and vitamin K epoxidase. | 1986 May 5 | 3699166 |
| Vitamin K-dependent carboxylase: evidence for cofractionation of carboxylase and epoxidase activities, and for carboxylation of a high-molecular-weight microsomal protein. | 1982 Mar | 7081994 |